| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 285.308 | 238.751 | 277.906 | 248.027 | 243.635 | 102.457 | 244.826 | 174.629 | 214.901 | 179.068 |
| Total Income - EUR | 437.865 | 365.379 | 411.906 | 394.809 | 392.919 | 319.620 | 335.579 | 354.312 | 270.708 | 338.515 |
| Total Expenses - EUR | 300.183 | 285.179 | 366.235 | 384.613 | 384.724 | 382.597 | 303.722 | 332.409 | 257.257 | 308.574 |
| Gross Profit/Loss - EUR | 137.683 | 80.200 | 45.671 | 10.196 | 8.195 | -62.977 | 31.857 | 21.903 | 13.451 | 29.941 |
| Net Profit/Loss - EUR | 126.526 | 72.549 | 35.978 | 7.545 | 5.716 | -63.877 | 29.368 | 20.142 | 11.305 | 25.016 |
| Employees | 11 | 11 | 15 | 13 | 11 | 8 | 4 | 2 | 2 | 2 |
Check the financial reports for the company - Rovexim Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 251.747 | 278.331 | 341.180 | 298.795 | 256.961 | 217.458 | 197.142 | 183.473 | 212.730 | 233.359 |
| Current Assets | 224.248 | 198.261 | 240.350 | 200.600 | 186.036 | 131.391 | 152.908 | 162.993 | 168.742 | 135.293 |
| Inventories | 78.329 | 77.367 | 109.995 | 101.951 | 122.887 | 87.610 | 73.272 | 108.084 | 67.887 | 71.339 |
| Receivables | 74.253 | 41.843 | 62.768 | 85.724 | 54.035 | 43.354 | 48.941 | 39.292 | 88.900 | 45.928 |
| Cash | 71.666 | 79.051 | 67.587 | 12.924 | 9.114 | 428 | 30.695 | 15.616 | 11.955 | 18.025 |
| Shareholders Funds | 279.259 | 275.821 | 300.935 | 297.395 | 296.757 | 222.560 | 246.992 | 267.900 | 256.418 | 243.977 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 196.736 | 200.771 | 280.595 | 201.999 | 146.240 | 126.289 | 103.057 | 78.566 | 125.055 | 124.675 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Rovexim Com Srl